Brief: Oncotelic Reports Q2 2022 Compared To Q2 2021 Financial Results
22/08/2022 14:08
Aug 22 (Reuters) - Oncotelic Therapeutics Inc OTLC.PK :
* ONCOTELIC REPORTS Q2 2022 COMPARED TO Q2 2021 FINANCIAL
RESULTS
* ONCOTELIC THERAPEUTICS INC- QTRLY NET PROFIT OF
APPROXIMATELY
$17.0 MILLION
Source text for Eikon: ID:nGNX4F6Hxg
Further company coverage: OTLC.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncotelic Therapeutics
See all newsBrief: Oncotelic Therapeutics Emerging As Leader With New Independent JV Valuation
Brief: Oncotelic Therapeutics - JV Is Preparing For A Potential Initial Public Offering On The Hong Kong Stock Exchange In Late 2026
Brief: Oncotelic Therapeutics To Sell Its Necroptosis Cancer Therapy Assets To Mosaic Immunoengineering
Brief: Oncotelic Announces Initiation Of Clinical Study In Non-Small Lung Cell Cancer
Brief: Oncotelic Initiates Clinical Trials Evaluating Ot-101 Against Pediatric Gliomas